South Africa, Drug Companies Spar Over Intellectual Property Laws

Reuters: South Africa slams Big Pharma in generic drugs row
“South Africa on Friday slammed global drug firms over a covert campaign against its planned overhaul of intellectual property laws to favor cheaper generic drugs, accusing pharmaceutical companies of a ‘satanic’ plot to commit ‘genocide.’ … South Africa is in the final stages of implementing a new law that would allow generic drugmakers to produce cut-price copies of patented medicines and make it harder for firms to register and roll over patents…” (Motsoeneng, 1/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.